Clinical Research Trials
The only FDA approved medications available to patients with Mild Cognitive Impairment and Alzheimer's disease are a class of medications that treat the symptoms of the disease. To date, there are no FDA approved medications aimed at slowing or potentially halting the progression of the disease.
If patients are eligible and interested, we will provide information about clinical trials. Most clinical trials are available to patients with Mild Cognitive Impairment and Alzheimer's disease in mild to moderate stages.
Contact us at 617-699-6927 to speak with one of our clinicians if you are interested in learning more about clinical trials.